Signed an Exclusive Distributorship Agreement with Texcell

Summit Pharmaceuticals International Corporation Statement for UK Modern Slavery Act 2015 (FY 2022 Statement)

Signing of Exclusive Distributorship Agreement with EVERZOM

Summit Pharmaceuticals International Corporation Statement for UK Modern Slavery Act 2015 (FY 2021 Statement)

Fukushima Medical University aim to accelerate cancer research by contributing their patient derived organoids to the CancerTools.org initiative

Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2020 Statement)

CytoReason and Summit Pharmaceuticals International Announce the Introduction of an AI Platform to One of Japan’s Top Pharmaceutical Companies

Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2019 Statement)

Summit Pharmaceuticals International Corporation Invests in Luxna Biotech Co., Ltd. Possessing the Nucleic Acid Pharmaceutical Element Technologies

Signed a Contract for Sale of Stem Cells from Human Exfoliated Deciduous Teeth between Gene Techno Science Co., Ltd. and Summit Pharmaceuticals International Corporation.

Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2018 Statement)

Establishment of a new cosmetics company